AU6088300A - Modulation of egr-1 and egr-2 in heart disease - Google Patents

Modulation of egr-1 and egr-2 in heart disease

Info

Publication number
AU6088300A
AU6088300A AU60883/00A AU6088300A AU6088300A AU 6088300 A AU6088300 A AU 6088300A AU 60883/00 A AU60883/00 A AU 60883/00A AU 6088300 A AU6088300 A AU 6088300A AU 6088300 A AU6088300 A AU 6088300A
Authority
AU
Australia
Prior art keywords
egr
modulation
heart disease
heart
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60883/00A
Inventor
Richard Einstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ore Pharmaceuticals Inc
Original Assignee
Ore Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ore Pharmaceuticals Inc filed Critical Ore Pharmaceuticals Inc
Publication of AU6088300A publication Critical patent/AU6088300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU60883/00A 1999-07-12 2000-07-12 Modulation of egr-1 and egr-2 in heart disease Abandoned AU6088300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14297399P 1999-07-12 1999-07-12
US60142973 1999-07-12
PCT/US2000/018923 WO2001004356A1 (en) 1999-07-12 2000-07-12 Modulation of egr-1 and egr-2 in heart disease

Publications (1)

Publication Number Publication Date
AU6088300A true AU6088300A (en) 2001-01-30

Family

ID=22502023

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60883/00A Abandoned AU6088300A (en) 1999-07-12 2000-07-12 Modulation of egr-1 and egr-2 in heart disease

Country Status (2)

Country Link
AU (1) AU6088300A (en)
WO (1) WO2001004356A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003060516A1 (en) * 2002-01-10 2003-07-24 Takeda Chemical Industries, Ltd. Screening method
AU2003245438A1 (en) * 2002-06-11 2003-12-22 Mucosal Therapeutics Llc Gene cluster analysis for coronary artery disease
WO2004050894A2 (en) * 2002-11-27 2004-06-17 Artesian Therapeutics, Inc. Heart failure gene determination and therapeutic screening
WO2004083435A1 (en) * 2003-03-17 2004-09-30 Julius-Maximilians-Uni Versität Würzburg Nab proteins and their use in diagnostic and therapeutic applications in heart disease
JP2007527377A (en) * 2003-06-30 2007-09-27 ジェノバ・リミテッド Secreted polypeptide species are reduced in cardiovascular disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726288A (en) * 1989-11-13 1998-03-10 Massachusetts Institute Of Technology Localization and characterization of the Wilms' tumor gene

Also Published As

Publication number Publication date
WO2001004356A1 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
AU2485100A (en) Left and right side heart support
AU3884701A (en) Cardiac methods and system
AU2710500A (en) Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
EP1076090A3 (en) ESTs and encoded human proteins
EP1076090A2 (en) ESTs and encoded human proteins
AU8905098A (en) Skin care compositions and use
AU2572499A (en) Human hairless gene, protein and uses thereof
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
AU715620C (en) Therapeutic methods and uses
AU4803997A (en) Polymorphisms and new genes in the region of the human hemochromatosis gene
AU7058000A (en) 13 human colon and colon cancer associated proteins
AU2121200A (en) Improvements in or relating to sphygmomanometers and other devices
AU2418499A (en) Org-5222 in the treatment of depression
AU1101901A (en) Human fgf-20 gene and gene expression products
AU2067501A (en) Human oxidoreductase proteins
AU2002224471A1 (en) In vivo stimulation of angiogenic activity
AU6088300A (en) Modulation of egr-1 and egr-2 in heart disease
AU3501700A (en) Human endokine alpha and methods of use
AU1321101A (en) Cholesterol lowering and blood lipids lowering composition
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
AU7410900A (en) Alginate preparation and use of the same
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
EP1173189A4 (en) Asialocytokines and treatment of liver disease
AU2669201A (en) Taccalonolides and their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase